Use of pooled residual laboratory sera to assess human immunodeficiency virus prevalence among patients in Italy
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
An anonymous unlinked seroprevalence study of human immunodeficiency virus (HIV) infection was performed by testing pools of ten sera remaining from specimens submitted consecutively to clinical pathology laboratories at 18 Italian public hospitals during four consecutive days in April 1991. Sera from positive pools were retested individually by three different enzyme immunoassays (EIAs) and considered positive if reactive by all three assays. Only the sera with discordant EIA results were retested by Western blot. Of a total of 22,590 sera, 278 were HIV positive (1.2 %). The highest rates were seen in hospitals located in metropolitan areas (1.5 %), in infectious disease departments (28 %) and in drug addiction treatment units (28 %); among men aged 21–30 (4.6 %) and 31–40 years (4 %); and among women aged 21–30 years (1.6 %). The distribution of seropositive patients by gender and age group suggests an increasing role of heterosexual transmission of the infection. The presence of anti-HIV antibodies in sera from patients of both sexes, in all age groups, and from all clinical settings reinforces the need for health care workers to adhere to universal precautions issued to prevent occupational bloodborne infections.
- Pappaioanou M, Dondero TJ, Petersen LR, Onorato IM, Sanchez CD, Curran JW The family of HIV seroprevalence surveys: objectives, methods, and uses of sentinel surveillance for HIV in the United States. Public Health Reports 1990, 105: 113–119.
- Newton L, Hall SM Unlinked anonymous monitoring of HIV prevalence in England and Wales: 1990–92. Communicable Disease Report 1993, 3: R1-R11.
- Behets F, Bertozzi S, Kasali M, Kashamuka M, Atikala L, Brown C, Ryder RW, Quinn TC Successful use of pooled sera to determine HIV-1 seroprevalence in Zaire with development of cost-efficiency models. AIDS 1990, 4: 737–741.
- Mawson S, Skidmore S, Pandov H, Desselberger U Anonymous testing for HIV infection. Lancet 1990, 335: 858–859. CrossRef
- Hansson BG, Hansson HB, Ohlin AK, Nordenfelt E Screening for anti-HIV and HBsAg in pooled sera from a clinical chemistry section as a tool for epidemiological survey. Scandinavian Journal of Infectious Diseases 1993, 25: 297–303.
- Des Jarlais DC, Friedman SR, Choopanya K, Vanichseni S, Ward TP International epidemiology of HIV and AIDS among injecting drug users. AIDS 1992, 6: 1053–1068.
- Jones TS, Allen DM, Onorato IM, Petersen LR, Dondero TJ, Pappaioanou M HIV seroprevalence surveys in drug treatment centers. Public Health Reports 1990, 105: 125–129.
- Onorato IM, McCray E, Pappaioanou M, Johnson R, Aral S, Hardy AM, Dondero TJ HIV seroprevalence surveys in sexually transmitted disease clinics. Public Health Reports 1990, 105: 119–124.
- Mertens TE, Hayes RJ, Smith PG Epidemiological methods to study the interaction between HIV infection and other sexually transmitted diseases. AIDS 1990, 4: 57–65.
- Petersen LR, Dodd R, Dondero TJ Methodologic approaches to surveillance of HIV infection among blood donors. Public Health Reports 1990, 105: 153–157.
- Pappaioanou M, George JR, Hannon WH, Gwinn M, Dondero TJ, Grady GF, Hoff R, Willoughby AD, Wright A, Novello AC, Curran JW HIV seroprevalence surveys of childbearing women. Objectives, methods, and uses of the data. Public Health Reports 1990, 105: 147–152.
- Ippolito G, Costa F, Stegagno M, Angeloni P, Angeloni U, Guzzanti E Blind serosurvey of HIV antibodies in newborns in 92 Italian hospitals: a method for monitoring the infection rate in women at time of delivery. Journal of Acquired Immune Deficiency Syndromes 1991, 4: 402–407.
- St. Louis ME, Olivo N, Critchley S, Rauch KJ, White CR, Munn VP, Dondero TJ Methods of surveillance of HIV infection at U.S. sentinel hospitals. Public Health Reports 1990, 105: 140–146.
- Novick LF New York State HIV seroprevalence project: goals, windows, and policy consideration. American Journal of Public Health 1991, 81: 11–14.
- World Health Organization Acquired immunodeficiency syndrome (AIDS). Proposed WHO criteria for interpreting results from Western blot assays for HIV-1, HIV-2, and HTLV-I/HTLV-II. Weekly Epidemiological Record 1990, 65: 281–283.
- Dean AD, Dean JA, Burton AH, Dicker RC EPI Info Version 5: a word processing, data base and statistics program for epidemiology on micro-computers. USD, Inc., Stone Mountain, GA, 1990.
- St. Louis ME, Rauch KJ, Petersen LR, Anderson JE, Schable CA, Dondero TJ, andthe Sentinel Hospital Surveillance Group Seroprevalence rates of human immunodeficiency virus infection at sentinel hospitals in the United States. New England Journal of Medicine 1990, 323: 213–218.
- Jansenn RS, St. Louis ME, Satten GA, Critchley SE, Petersen LR, Stafford RS, Ward JW, Hanson DL, Olivo N, Schable CA, Dondero TJ, andthe Hospital Surveillance Group HIV infection among patients in U.S. acute care hospitals. Strategies for the counseling and testing of hospital patients. New England Journal of Medicine 1992, 327: 445–452.
- Commissione Nazionale per la lotta contro l'AIDS, Ministero della Sanita' Aggiornamento dell'epidemiologia dell'AIDS e dell'infezione da HIV in Italia al 1992. Giornale Italiano dell'AIDS 1992 3: 127–171.
- Consiglio Nazionale delle Ricerche — Ministero della Sanita' Stima del numero di sostanze stupefacenti e psicotrope in Italia. In: Rapporto droga-Italia 1977-78-79. CNR-Giardini, Pisa, 1980: 149–176.
- Angarano G, Pastore G, Monno L, Santantonio T, Luchena N, Schiraldi O Rapid spread of HTLV-III infection among drug addicts in Italy. Lancet 1985, ii: 1302. CrossRef
- Charache P, Cameron JL, Maters AW, Frantz EI Prevalence of infection with human immunodeficiency virus in elective surgery patients. Annals of Surgery 1991, 214: 562–568.
- World Health Organization Testing for HIV antibody in serum pools. Bulletin of the World Health Organization 1992, 70: 277–280.
- Cahoon-Young B, Chandler A, Livermore T, Gaudino J, Benjamin R Sensitivity and specificity of pooled versus individual sera in a human immunodeficiency virus (HIV) antibody prevalence study. Journal of Clinical Microbiology 1989, 27: 1893–1895.
- Frosner GG, Dobler G, Falkner von Sonnenburg FJ Cost reduction of unlinked testing for anti-HIV by investigation of pooled sera. AIDS 1990, 4: 73–75.
- Kline RL, Brothers TA, Brookmeyer R, Zeger S, Quinn TC Evaluation of human immunodeficiency virus (HIV) seroprevalence in population surveys using pooled sera. Journal of Clinical Microbiology 1989, 27: 1449–1455.
- World Health Organization Recommendations for the selection and use of HIV antibody tests. Weekly Epidemiological Record 1992, 67: 145–149.
- Centers for Disease Control Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus and other bloodborne pathogens in health care settings. Mortality and Morbidity Weekly Report 1988, 37: 377–382, 387–388.
- Use of pooled residual laboratory sera to assess human immunodeficiency virus prevalence among patients in Italy
European Journal of Clinical Microbiology and Infectious Diseases
Volume 13, Issue 3 , pp 205-211
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Unita' Operativa AIDS RM-10, Ospedale L. Spallanzani, via Portuense 292, 00149, Rome, Italy
- 2. Laboratorio di Virologia, Ospedale San Camillo, Rome, Italy
- 3. Laboratorio di Patologia Clinica e Microbiologia, Ospedale C. Forlanini, Rome, Italy